ENTITY
Sihuan Pharmaceutical Hldgs

Sihuan Pharmaceutical Hldgs (460 HK)

73
Analysis
Health Care • China
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
bullish•Jacobson Pharma
•13 Sep 2016 12:23

Jacobson Pharma IPO -- Home Team Advantage

Jacobson Pharmaceutical Corporation Limited is a pending listing on the HKEX. This Insight forks Toh Zhen Zhou 's Insight Jacobson Pharma IPO -...

Share
•12 Sep 2016 23:18

Iran Shows China the Way on Population Expansion

Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...

Logo
298 Views
Share
•23 Aug 2016 01:17

Coal Burning Major Cause of Health Problems in China

A comprehensive study published last week by Tsinghua University and the Health Effects Institute found that coal combustion is the single largest...

Logo
286 Views
Share
•18 Aug 2016 18:43

Small Improvement in China Air Quality

Air quality in China appears to have improved slightly in recent months. However, it is still well above World Health Organisation recommended...

Logo
315 Views
Share
•04 Aug 2016 16:39

Critique of Genome Scientific Work

China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...

Logo
336 Views
Share
x